 |
Turna Ray is the editor of GenomeWeb's Pharmacogenomics Reporter. She covers pharmacogenomics, personalized medicine, and companion diagnostics. E-mail Turna Ray or follow her GenomeWeb Twitter account at @PGxReporter. |
During Investor Day, Roche Highlights Personalized Medicine as Key Area for Future Growth
September 12, 2012
During Investor Day, Roche Highlights Personalized Medicine as Key Area for Future Growth
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- PGx Drugs Xalkori, Zelboraf Show Strong Growth in First Quarter of 2013
May 1, 2013 / Pharmacogenomics Reporter - Ventana's Growing Companion Dx Focus Mirrors Parent Roche's Investment in Personalized Rx
January 18, 2012 / Pharmacogenomics Reporter - Drugmakers' Commitment to Personalized Rx Growing Despite Barriers, PhRMA CEO Says
June 15, 2011 / Pharmacogenomics Reporter - FDA Approves Genentech's Antibody-Drug Conjugate, Marking Third Rx for HER2-Targeted Breast Cancer
February 27, 2013 / Pharmacogenomics Reporter - Genentech Planning Regulatory Filing This Year for New Personalized Rx for Advanced Breast Cancer
June 6, 2012 / Pharmacogenomics Reporter